Indefinite Delivery Contract SPE2DP18D0005
Award Date 6/27/18
Last Date to Order 6/26/19
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Pricing Type
Firm Fixed Price
Legislative Mandate
Not listed National Interest Action
None
Award Type
Single
Primary Consortia Member
Not listed Similar IDVs
- This Indefinite Delivery Contract (IDC) was awarded by the Defense Logistics Agency's Medical Supply Chain unit to Seqirus USA Inc., a global biotechnology company specializing in influenza vaccine development and delivery. The contract, valued at $36,120,112.50, aims to procure approximately 3.23 million doses of injectable influenza virus vaccines in multi-dose vials and pre-filled syringes for various age groups, including elderly, adult, and pediatric populations. The vaccines are intended...
- This Indefinite Delivery Contract (IDC) was awarded by the Centers for Disease Control and Prevention (CDC) to Seqirus USA Inc., a global biotechnology company specializing in influenza vaccine development and delivery. The $143 million IDC is for the supply of adult influenza vaccines, and a separate $208 million IDC is for pediatric influenza vaccines, to support the CDC's nationwide immunization programs from 2022-2023. Seqirus USA Inc. has also been awarded several other high-value...
- This Indefinite Delivery Contract (IDC) was awarded by the Centers for Disease Control and Prevention (CDC), a civilian agency within the U.S. Department of Health and Human Services, to Seqirus USA Inc. through its Seqirus Usa, Inc. division. The contract has a ceiling value of $167,880,000 and is for the delivery of seasonal influenza vaccines during the 2018-2019 flu season. Seqirus is a global biotechnology company specializing in the development, manufacturing, and delivery of influenza...
- This Indefinite Delivery Contract (IDC) was awarded by the Defense Logistics Agency's Medical Supply Chain, a defense agency, to Seqirus USA Inc., a foreign-owned, for-profit manufacturer of influenza vaccines. The $6.86 million single-award IDC is for the delivery of influenza virus vaccines over the period from February 2025 to February 2026. Seqirus USA Inc. is a significant federal contractor in this space, holding several large IDCs with agencies like the Department of Veterans Affairs...
- This indefinite delivery contract (IDC) was awarded by the Centers for Disease Control and Prevention (CDC), a civilian agency within the Department of Health and Human Services, to Seqirus USA Inc. The contract has a ceiling value of $27,015,000 and is for the delivery of adult influenza vaccines for the 2019-2020 flu season. Seqirus USA Inc., through its Seqirus USA, Inc. division, is a global biotechnology company specializing in the development, manufacturing, and delivery of influenza...
- This Indefinite Delivery Contract (IDC) was awarded by the Centers for Disease Control and Prevention (CDC) to Seqirus USA Inc. to provide pediatric and adult influenza vaccines for the 2022-2023 season. The contract has a total ceiling value of $381,759,818.50 and covers the period from January 3, 2019 to February 28, 2019. Seqirus USA Inc., a global biotechnology company specializing in influenza vaccine development and delivery, will serve as the prime contractor on this multiple award IDC to...
- Seqirus USA Inc. has been awarded a multiple-award Indefinite Delivery Contract by the Centers for Disease Control and Prevention (CDC) for the procurement of adult influenza vaccines under the 2025-6 program cycle. The contract carries a ceiling value of $245.582 million with an ultimate completion date of February 28, 2026, and was awarded on December 31, 2024. This civilian contract utilizes no set-aside designation, reflecting open competition in the federal influenza vaccine marketplace....
- This Indefinite Delivery Contract (IDC) was awarded by the Centers for Disease Control and Prevention (CDC) to Seqirus USA Inc., a global biotechnology company specializing in influenza vaccine development, manufacturing, and delivery. The $143,324,800 contract is for the procurement of adult influenza vaccines for the 2022-2023 flu season, with a period of performance from the award date of December 31, 2021 through February 28, 2023. The contract does not utilize any set-asides and was awarded...
- The Centers for Disease Control and Prevention awarded Seqirus USA Inc. a multiple award indefinite delivery contract with a potential value of $129.8 million to supply pediatric influenza vaccines through February 2028. Task orders will be issued against the contract to procure required vaccines annually to support the CDC's national immunization programs. As a leading manufacturer of influenza vaccines, Seqirus will deliver various formulations of pediatric flu vaccines to the CDC for...
- The federal contract IDV being summarized is a multiple award Indefinite Delivery Contract (IDC) awarded by the Centers for Disease Control and Prevention (CDC) to Seqirus USA Inc. for the delivery of adult influenza vaccines for the 2024-2025 flu season. The $215,741,000 IDC covers a range of influenza vaccine products and presentations, including multi-dose vials, pre-filled syringes, and specialized formulations for different age groups. Seqirus, a foreign-owned for-profit manufacturer,...
Name | Description | Awardee | Potential Value | AwardDate | CompletionDate | Updated At |
|---|---|---|---|---|---|---|
Delivery Order SPE2DP18D0005-SPE2DP19F1314 | Seqirus USA Inc. | $21.7k | 12/18/18 | 1/2/19 | 12/18/18 | |
Delivery Order SPE2DP18D0005-SPE2DP19F0726 | Seqirus USA Inc. | $25.6k | 11/15/18 | 11/30/18 | 11/15/18 | |
Delivery Order SPE2DP18D0005-SPE2DP19F0319 | Seqirus USA Inc. | $179.9k | 10/16/18 | 11/5/18 | 10/16/18 | |
Delivery Order SPE2DP18D0005-SPE2DP19F0395 | Seqirus USA Inc. | $26.5k | 10/22/18 | 10/26/18 | 10/22/18 | |
Delivery Order SPE2DP18D0005-SPE2DP19F1582 | Seqirus USA Inc. | $2.4k | 1/10/19 | 1/30/19 | 1/10/19 |